LWT, ISSN 0023-6438, 06/2018, Volume 92, pp. 40 - 46
This study was done to isolate novel antioxidant peptides from Chinese chestnut protein (CCP) hydrolysed with alcalase. A series of purification steps...
Chinese chestnut | Hydrolysis | Peptide synthesis | Purification | Antioxidant activity | INHIBITORY PEPTIDES | BIOACTIVE PEPTIDES | FOOD SCIENCE & TECHNOLOGY | BY-PRODUCTS
Chinese chestnut | Hydrolysis | Peptide synthesis | Purification | Antioxidant activity | INHIBITORY PEPTIDES | BIOACTIVE PEPTIDES | FOOD SCIENCE & TECHNOLOGY | BY-PRODUCTS
Journal Article
Annals of Hematology, ISSN 0939-5555, 11/2019
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 5271 - 5271
Abstract Background: Cysteine and glycine-rich protein 2 (CSRP2), a member of the CSRP family, is reported to be upregulated in highly invasive breast cancer...
Journal Article
British Journal of Haematology, ISSN 0007-1048, 06/2019, Volume 185, Issue 5, pp. 836 - 851
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 5157 - 5157
Abstract Abstract Background: Chemokine (C-C Motif) Ligand 17 is a protein coding gene. This chemokine plays important roles in T cell development in thymus as...
Journal Article
Journal of Cellular and Molecular Medicine, ISSN 1582-1838, 08/2019, Volume 23, Issue 8, pp. 5672 - 5678
A high frequency of MAGE‐CT (cancer testis) antigens are expressed in Multiple Myeloma (MM) patients; however, in other plasma cell dyscrasias, their potential...
real‐time quantitative polymerase chain reaction | cancer‐testis antigen gene | amyloid light‐chain amyloidosis | MULTIPLE-MYELOMA | ORGAN INVOLVEMENT | LACTATE-DEHYDROGENASE | SURVIVAL | CRITERIA | MEDICINE, RESEARCH & EXPERIMENTAL | MARKER | real-time quantitative polymerase chain reaction | cancer-testis antigen gene | CELL BIOLOGY | MAGE-C1/CT7 | LIGHT-CHAIN AMYLOIDOSIS | CLINICAL PRESENTATION | IMMUNOTHERAPY | amyloid light-chain amyloidosis | Genetic research | Amyloidosis | Gene expression | Genes | Multiple myeloma | Antigens | Data analysis | Research & development--R&D | Vaccines | Grants | Patients | CT gene | Polymerase chain reaction | Proteins | Studies | Immunotherapy | Medical prognosis | Bone marrow | Paraproteinemia | Amyloid | Indicators | Original
real‐time quantitative polymerase chain reaction | cancer‐testis antigen gene | amyloid light‐chain amyloidosis | MULTIPLE-MYELOMA | ORGAN INVOLVEMENT | LACTATE-DEHYDROGENASE | SURVIVAL | CRITERIA | MEDICINE, RESEARCH & EXPERIMENTAL | MARKER | real-time quantitative polymerase chain reaction | cancer-testis antigen gene | CELL BIOLOGY | MAGE-C1/CT7 | LIGHT-CHAIN AMYLOIDOSIS | CLINICAL PRESENTATION | IMMUNOTHERAPY | amyloid light-chain amyloidosis | Genetic research | Amyloidosis | Gene expression | Genes | Multiple myeloma | Antigens | Data analysis | Research & development--R&D | Vaccines | Grants | Patients | CT gene | Polymerase chain reaction | Proteins | Studies | Immunotherapy | Medical prognosis | Bone marrow | Paraproteinemia | Amyloid | Indicators | Original
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 07/2019, Volume 60, Issue 9, pp. 2181 - 2189
Acute myeloid leukemia (AML) patients with biallelic CEBPA (bi CEBPA) mutations are considered prognostically favorable, but 38-58% of them still relapse....
multiparameter flow cytometry | biallelic CEBPA mutations | minimal residual disease | risk stratification treatment | relapse | Acute myeloid leukemia | AML | DIAGNOSIS | MANAGEMENT | ADULTS | TET2 | IMPACT | THERAPY | ONCOLOGY | RECOMMENDATIONS | OUTCOMES | STEM-CELL TRANSPLANTATION | HEMATOLOGY
multiparameter flow cytometry | biallelic CEBPA mutations | minimal residual disease | risk stratification treatment | relapse | Acute myeloid leukemia | AML | DIAGNOSIS | MANAGEMENT | ADULTS | TET2 | IMPACT | THERAPY | ONCOLOGY | RECOMMENDATIONS | OUTCOMES | STEM-CELL TRANSPLANTATION | HEMATOLOGY
Journal Article
British Journal of Haematology, ISSN 0007-1048, 06/2019, Volume 185, Issue 5, pp. 836 - 851
Summary Refinement of risk stratification in Philadelphia chromosome (Ph)‐negative B‐cell acute lymphoblastic leukaemia (ALL) might aid the identification of...
ERK1/2 | B‐cell acute lymphoblastic leukaemia | S100A16 | relapse | PI3K/AKT | B-cell acute lymphoblastic leukaemia | Chemotherapy | Relapse | Analysis | Protein binding | Diseases | Cancer | Biotechnology | Level (quantity) | Cell survival | Acute lymphatic leukemia | Transcription | Calcium | Leukemia | Extracellular signal-regulated kinase | AKT protein | Multivariate analysis | Survival | Western blotting | 1-Phosphatidylinositol 3-kinase | Philadelphia chromosome | Signal transduction | Lymphocytes B | Calcium-binding protein | Cell lines | Remission | Adults | Apoptosis | Function analysis
ERK1/2 | B‐cell acute lymphoblastic leukaemia | S100A16 | relapse | PI3K/AKT | B-cell acute lymphoblastic leukaemia | Chemotherapy | Relapse | Analysis | Protein binding | Diseases | Cancer | Biotechnology | Level (quantity) | Cell survival | Acute lymphatic leukemia | Transcription | Calcium | Leukemia | Extracellular signal-regulated kinase | AKT protein | Multivariate analysis | Survival | Western blotting | 1-Phosphatidylinositol 3-kinase | Philadelphia chromosome | Signal transduction | Lymphocytes B | Calcium-binding protein | Cell lines | Remission | Adults | Apoptosis | Function analysis
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 04/2018, Volume 24, Issue 4, pp. 741 - 750
Here we compare outcomes between the tyrosine kinase inhibitors (TKIs) plus chemotherapy regimen and allogeneic hematopoietic stem cell transplantation...
Philadelphia chromosome–positive acute lymphoblastic leukemia | Allogeneic stem cell transplantation | Molecular response | Tyrosine kinase inhibitors | ADULT PATIENTS | IMATINIB-COMBINED CHEMOTHERAPY | IMMUNOLOGY | Philadelphia chromosome-positive acute lymphoblastic leukemia | TRANSPLANTATION | TRIAL | HYPER-CVAD | IMPACT | POLYMERASE-CHAIN-REACTION | THERAPY | HEMATOLOGY | MINIMAL RESIDUAL DISEASE | REMISSION | Tyrosine | Medical research | Care and treatment | Transplantation | Risk factors | Hematopoietic stem cells | Chemotherapy | Analysis | Stem cells | Medicine, Experimental | Phenols | Genetic research | Genetic aspects | Acute lymphocytic leukemia | Cancer
Philadelphia chromosome–positive acute lymphoblastic leukemia | Allogeneic stem cell transplantation | Molecular response | Tyrosine kinase inhibitors | ADULT PATIENTS | IMATINIB-COMBINED CHEMOTHERAPY | IMMUNOLOGY | Philadelphia chromosome-positive acute lymphoblastic leukemia | TRANSPLANTATION | TRIAL | HYPER-CVAD | IMPACT | POLYMERASE-CHAIN-REACTION | THERAPY | HEMATOLOGY | MINIMAL RESIDUAL DISEASE | REMISSION | Tyrosine | Medical research | Care and treatment | Transplantation | Risk factors | Hematopoietic stem cells | Chemotherapy | Analysis | Stem cells | Medicine, Experimental | Phenols | Genetic research | Genetic aspects | Acute lymphocytic leukemia | Cancer
Journal Article
BMC Cancer, ISSN 1471-2407, 04/2016, Volume 16, Issue 1, p. 269
Background: Interrogate the impact of IKZF1 deletion on therapy-outcomes of adults with common B-cell acute lymphoblastic leukemia. Methods: One hundred...
Chemotherapy | IKZF1 | Acute lymphoblastic leukemia | Allotransplant | BCR-ABL1 | HLA-MISMATCHED/HAPLOIDENTICAL BLOOD | PRECURSOR | ONCOLOGY | IKAROS | MARROW-TRANSPLANTATION | MINIMAL RESIDUAL DISEASE | GENETIC ALTERATIONS | Sequence Deletion | Prognosis | Humans | Middle Aged | Male | Transplantation, Homologous | Ikaros Transcription Factor - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Disease-Free Survival | Fusion Proteins, bcr-abl - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy | Adolescent | Adult | Female | Aged | B-Lymphocytes - pathology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | B-Lymphocytes - transplantation | Analysis | Physiological aspects | Genetic aspects | Adults | Acute lymphocytic leukemia | B cells
Chemotherapy | IKZF1 | Acute lymphoblastic leukemia | Allotransplant | BCR-ABL1 | HLA-MISMATCHED/HAPLOIDENTICAL BLOOD | PRECURSOR | ONCOLOGY | IKAROS | MARROW-TRANSPLANTATION | MINIMAL RESIDUAL DISEASE | GENETIC ALTERATIONS | Sequence Deletion | Prognosis | Humans | Middle Aged | Male | Transplantation, Homologous | Ikaros Transcription Factor - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Disease-Free Survival | Fusion Proteins, bcr-abl - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy | Adolescent | Adult | Female | Aged | B-Lymphocytes - pathology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | B-Lymphocytes - transplantation | Analysis | Physiological aspects | Genetic aspects | Adults | Acute lymphocytic leukemia | B cells
Journal Article
Leukemia Research, ISSN 0145-2126, 05/2015, Volume 39, Issue 5, pp. 510 - 514
CALR mutations are detected in about 50% of persons of predominately European descent with essential thrombocythemia (ET) or primary myelofibrosis (PMF) with...
Calreticulin | Allele burden | Mutation | Myeloproliferative neoplasm
Calreticulin | Allele burden | Mutation | Myeloproliferative neoplasm
Journal Article
Clinical and Experimental Medicine, ISSN 1591-8890, 11/2014, Volume 14, Issue 4, pp. 457 - 460
The Abelson (ABL) gene was the best control gene for quantitative PCR (qPCR)-based diagnosis and minimal residual disease detection in leukemic patients....
Medicine & Public Health | Hematology | Multiple myeloma | Abelson | Internal Medicine | Oncology | MAGE-C1 | qPCR | GAPDH | MEDICINE, RESEARCH & EXPERIMENTAL | RT-PCR | ASSAYS | Antigens, Neoplasm - genetics | Multiple Myeloma - diagnosis | Humans | Real-Time Polymerase Chain Reaction - methods | Real-Time Polymerase Chain Reaction - standards | Gene Expression Profiling | Glyceraldehyde-3-Phosphate Dehydrogenases - genetics | Reference Standards | Glucuronidase - genetics | Bone Marrow - pathology | Genes, abl | Neoplasm Proteins - genetics | Multiple Myeloma - genetics | beta 2-Microglobulin - genetics | Phosphates | Leukemia | Genes | Transplantation | Gene expression | Hematopoietic stem cells | Monosaccharides | Polymerase chain reaction | Analysis | Genetic research | Genetic aspects | Sugars | Cancer
Medicine & Public Health | Hematology | Multiple myeloma | Abelson | Internal Medicine | Oncology | MAGE-C1 | qPCR | GAPDH | MEDICINE, RESEARCH & EXPERIMENTAL | RT-PCR | ASSAYS | Antigens, Neoplasm - genetics | Multiple Myeloma - diagnosis | Humans | Real-Time Polymerase Chain Reaction - methods | Real-Time Polymerase Chain Reaction - standards | Gene Expression Profiling | Glyceraldehyde-3-Phosphate Dehydrogenases - genetics | Reference Standards | Glucuronidase - genetics | Bone Marrow - pathology | Genes, abl | Neoplasm Proteins - genetics | Multiple Myeloma - genetics | beta 2-Microglobulin - genetics | Phosphates | Leukemia | Genes | Transplantation | Gene expression | Hematopoietic stem cells | Monosaccharides | Polymerase chain reaction | Analysis | Genetic research | Genetic aspects | Sugars | Cancer
Journal Article
Leukemia & lymphoma, 02/2019, p. 1
Acute myeloid leukemia (AML) patients with biallelic CEBPA (bi CEBPA) mutations are considered prognostically favorable, but 38-58% of them still relapse....
Journal Article
Blood, ISSN 0006-4971, 11/2012, Volume 120, Issue 21, pp. 1397 - 1397
Abstract Abstract 1397 Background: Using neonatal NOD/SCID/IL2rγnull xenotransplantation model, we previously demonstrated that CD34+CD38+CD19+ cells as well...
Journal Article
Apoptosis, ISSN 1360-8185, 10/2016, Volume 21, Issue 10, pp. 1179 - 1190
V-set and transmembrane domain-containing 1 (VSTM1), which is downregulated in bone marrow cells from leukemia patients, may provide a diagnostic and treatment...
Biochemistry, general | Biomedicine | Daunorubicin | VSTM1 gene | Leukemia | Cancer Research | Oncology | Gene therapy | Cell Biology | Virology | Oncolytic adenovirus | EFFICACY | SIGNAL INHIBITORY RECEPTOR | BIOCHEMISTRY & MOLECULAR BIOLOGY | CANCER | CELL BIOLOGY | HEPATOCELLULAR-CARCINOMA | IMMUNOTHERAPY | MYELOID-LEUKEMIA | GENE-THERAPY | DIFFERENTIATION | HUMAN PHAGOCYTES | LEUKOCYTES-1 | Genetic Therapy | Leukemia - physiopathology | Apoptosis - drug effects | Humans | Antineoplastic Agents - administration & dosage | Adenoviridae - genetics | Female | Daunorubicin - administration & dosage | Leukemia - virology | Genetic Vectors - metabolism | Leukemia - drug therapy | Leukemia - therapy | Adenoviridae - physiology | Oncolytic Viruses - genetics | Combined Modality Therapy | Genetic Vectors - genetics | Oncolytic Virotherapy | Animals | Mice, Nude | Oncolytic Viruses - physiology | Cell Line, Tumor | Mice | Mice, Inbred BALB C | Receptors, Immunologic - genetics | Receptors, Immunologic - metabolism | Antimitotic agents | Anopheles | Adenoviruses | Analysis | Genes | Transplantation | Antineoplastic agents | Gene expression | Telomerase | Hematopoietic stem cells
Biochemistry, general | Biomedicine | Daunorubicin | VSTM1 gene | Leukemia | Cancer Research | Oncology | Gene therapy | Cell Biology | Virology | Oncolytic adenovirus | EFFICACY | SIGNAL INHIBITORY RECEPTOR | BIOCHEMISTRY & MOLECULAR BIOLOGY | CANCER | CELL BIOLOGY | HEPATOCELLULAR-CARCINOMA | IMMUNOTHERAPY | MYELOID-LEUKEMIA | GENE-THERAPY | DIFFERENTIATION | HUMAN PHAGOCYTES | LEUKOCYTES-1 | Genetic Therapy | Leukemia - physiopathology | Apoptosis - drug effects | Humans | Antineoplastic Agents - administration & dosage | Adenoviridae - genetics | Female | Daunorubicin - administration & dosage | Leukemia - virology | Genetic Vectors - metabolism | Leukemia - drug therapy | Leukemia - therapy | Adenoviridae - physiology | Oncolytic Viruses - genetics | Combined Modality Therapy | Genetic Vectors - genetics | Oncolytic Virotherapy | Animals | Mice, Nude | Oncolytic Viruses - physiology | Cell Line, Tumor | Mice | Mice, Inbred BALB C | Receptors, Immunologic - genetics | Receptors, Immunologic - metabolism | Antimitotic agents | Anopheles | Adenoviruses | Analysis | Genes | Transplantation | Antineoplastic agents | Gene expression | Telomerase | Hematopoietic stem cells
Journal Article
ONCOTARGET, ISSN 1949-2553, 05/2017, Volume 8, Issue 22, pp. 35984 - 36000
Relapse is the major cause of treatment-failure in adults with B-cell acute lymphoblastic leukemia (ALL) achieving complete remission after induction...
HLA-MISMATCHED/HAPLOIDENTICAL BLOOD | prognostic factor | relapse | CANCER PROGRAM | CHRONIC MYELOID-LEUKEMIA | ARRAY ANALYSIS | CELL BIOLOGY | HEPATOCELLULAR-CARCINOMA | CSRP2 | POLYMERASE-CHAIN-REACTION | acute lymphoblastic leukemia | RESIDUAL DISEASE DETECTION | GENES | drug resistance | MARROW-TRANSPLANTATION | EXPRESSION | Cell Cycle - genetics | Recurrence | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Cell Proliferation | Prognosis | Humans | Male | LIM Domain Proteins - metabolism | Neoplasm, Residual | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Muscle Proteins - metabolism | Adult | Female | Cytogenetic Analysis | Nuclear Proteins - genetics | Gene Expression | Immunophenotyping | Nuclear Proteins - metabolism | Muscle Proteins - genetics | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Xenograft Model Antitumor Assays | Animals | Biomarkers | Cell Line, Tumor | LIM Domain Proteins - genetics | Mice | Apoptosis
HLA-MISMATCHED/HAPLOIDENTICAL BLOOD | prognostic factor | relapse | CANCER PROGRAM | CHRONIC MYELOID-LEUKEMIA | ARRAY ANALYSIS | CELL BIOLOGY | HEPATOCELLULAR-CARCINOMA | CSRP2 | POLYMERASE-CHAIN-REACTION | acute lymphoblastic leukemia | RESIDUAL DISEASE DETECTION | GENES | drug resistance | MARROW-TRANSPLANTATION | EXPRESSION | Cell Cycle - genetics | Recurrence | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Cell Proliferation | Prognosis | Humans | Male | LIM Domain Proteins - metabolism | Neoplasm, Residual | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Muscle Proteins - metabolism | Adult | Female | Cytogenetic Analysis | Nuclear Proteins - genetics | Gene Expression | Immunophenotyping | Nuclear Proteins - metabolism | Muscle Proteins - genetics | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Xenograft Model Antitumor Assays | Animals | Biomarkers | Cell Line, Tumor | LIM Domain Proteins - genetics | Mice | Apoptosis
Journal Article
Leukemia Research, ISSN 0145-2126, 06/2013, Volume 37, Issue 6, pp. 624 - 630
To explore the prognostic value of CD34 expression in NPM1-mutated acute myeloid leukemia (NPM1m + AML), seventy-one NPM1m + AML patients were retrospectively...
Journal Article
Leukemia Research, ISSN 0145-2126, 2013, Volume 37, Issue 6, pp. 624 - 630
Abstract To explore the prognostic value of CD34 expression in NPM1-mutated acute myeloid leukemia (NPM1m + AML), seventy-one NPM1m + AML patients were...
Hematology, Oncology and Palliative Medicine | Nucleophosmin mutation | Prognosis | Acute myeloid leukemia | CD34 | FLT3-ITD | ADULT PATIENTS | ACUTE MYELOGENOUS LEUKEMIA | TANDEM DUPLICATION | PREVALENCE | ONCOLOGY | RECOMMENDATIONS | FAVORABLE PROGNOSIS | RELEVANCE | NUCLEOPHOSMIN NPM1 | MUTATIONS | HEMATOLOGY | ELDERLY-PATIENTS | Antigens, CD34 - metabolism | Humans | Leukemia, Myeloid, Acute - metabolism | Middle Aged | Male | Young Adult | fms-Like Tyrosine Kinase 3 - genetics | Mutation - physiology | Aged, 80 and over | Adult | Female | Nuclear Proteins - genetics | Child | Tandem Repeat Sequences - genetics | Granulocyte Precursor Cells - metabolism | Bone Marrow Cells - pathology | Granulocyte Precursor Cells - pathology | Leukemia, Myeloid, Acute - mortality | Leukemia, Myeloid, Acute - diagnosis | Adolescent | Survival Analysis | Aged | Bone Marrow Cells - metabolism | Leukemia, Myeloid, Acute - genetics
Hematology, Oncology and Palliative Medicine | Nucleophosmin mutation | Prognosis | Acute myeloid leukemia | CD34 | FLT3-ITD | ADULT PATIENTS | ACUTE MYELOGENOUS LEUKEMIA | TANDEM DUPLICATION | PREVALENCE | ONCOLOGY | RECOMMENDATIONS | FAVORABLE PROGNOSIS | RELEVANCE | NUCLEOPHOSMIN NPM1 | MUTATIONS | HEMATOLOGY | ELDERLY-PATIENTS | Antigens, CD34 - metabolism | Humans | Leukemia, Myeloid, Acute - metabolism | Middle Aged | Male | Young Adult | fms-Like Tyrosine Kinase 3 - genetics | Mutation - physiology | Aged, 80 and over | Adult | Female | Nuclear Proteins - genetics | Child | Tandem Repeat Sequences - genetics | Granulocyte Precursor Cells - metabolism | Bone Marrow Cells - pathology | Granulocyte Precursor Cells - pathology | Leukemia, Myeloid, Acute - mortality | Leukemia, Myeloid, Acute - diagnosis | Adolescent | Survival Analysis | Aged | Bone Marrow Cells - metabolism | Leukemia, Myeloid, Acute - genetics
Journal Article
LEUKEMIA RESEARCH, ISSN 0145-2126, 05/2015, Volume 39, Issue 5, pp. 510 - 514
CALR mutations are detected in about 50% of persons of predominately European descent with essential thrombocythemia (ET) or primary myelofibrosis (PMF) with...
POLYCYTHEMIA-VERA | SUBTYPES | JAK2 V617F MUTATION | MYELOPROLIFERATIVE NEOPLASMS | DISORDERS | W515L/K MUTATIONS | JAK2V617F | FEATURES | Calreticulin | ONCOLOGY | Allele burden | Mutation | HEMATOLOGY | Myeloproliferative neoplasm | Humans | Middle Aged | Asian Continental Ancestry Group - genetics | Molecular Sequence Data | Male | Primary Myelofibrosis - ethnology | Thrombocythemia, Essential - genetics | Calreticulin - genetics | Young Adult | Thrombocythemia, Essential - ethnology | Base Sequence | Aged, 80 and over | Adult | Female | Amino Acid Sequence | Gene Frequency | Janus Kinase 2 - genetics | Genotype | Receptors, Thrombopoietin - genetics | Primary Myelofibrosis - genetics | Phenylalanine - genetics | Adolescent | Valine - genetics | Aged | Amino Acid Substitution
POLYCYTHEMIA-VERA | SUBTYPES | JAK2 V617F MUTATION | MYELOPROLIFERATIVE NEOPLASMS | DISORDERS | W515L/K MUTATIONS | JAK2V617F | FEATURES | Calreticulin | ONCOLOGY | Allele burden | Mutation | HEMATOLOGY | Myeloproliferative neoplasm | Humans | Middle Aged | Asian Continental Ancestry Group - genetics | Molecular Sequence Data | Male | Primary Myelofibrosis - ethnology | Thrombocythemia, Essential - genetics | Calreticulin - genetics | Young Adult | Thrombocythemia, Essential - ethnology | Base Sequence | Aged, 80 and over | Adult | Female | Amino Acid Sequence | Gene Frequency | Janus Kinase 2 - genetics | Genotype | Receptors, Thrombopoietin - genetics | Primary Myelofibrosis - genetics | Phenylalanine - genetics | Adolescent | Valine - genetics | Aged | Amino Acid Substitution
Journal Article
Leukemia Research, ISSN 0145-2126, 2013, Volume 37, Issue 7, pp. 737 - 741
Abstract Acute myeloid leukemia with mutated nucleophosmin (NPM1m+AML) is a heterogeneous entity. We investigated whether NPM1m+AML with monocytic or myeloid...
Hematology, Oncology and Palliative Medicine | Flow cytometry | Nucleophosmin mutation | Immunophenotype | Acute myeloid leukemia | GENE-MUTATIONS | AML | CYTOPLASMIC NUCLEOPHOSMIN | ACUTE MYELOGENOUS LEUKEMIA | CLASSIFICATION | TANDEM DUPLICATION | NORMAL KARYOTYPE | ONCOLOGY | FAVORABLE PROGNOSIS | NPM1 MUTATION | HEMATOLOGY | EXPRESSION | Antigens, CD - immunology | Prognosis | Humans | Middle Aged | Child, Preschool | Male | Monocytes - immunology | Leukemia, Myeloid, Acute - immunology | Antigens, CD - metabolism | Young Adult | Flow Cytometry | Myeloid Cells - immunology | Monocytes - pathology | Aged, 80 and over | Adult | Female | Retrospective Studies | Nuclear Proteins - genetics | Child | HLA-DR Antigens - metabolism | Leukemia, Myeloid, Acute - pathology | Immunophenotyping | Mutation - genetics | Adolescent | Chromosome Aberrations | Aged | HLA-DR Antigens - immunology | Myeloid Cells - pathology | Leukemia, Myeloid, Acute - genetics | Fc receptors | Analysis
Hematology, Oncology and Palliative Medicine | Flow cytometry | Nucleophosmin mutation | Immunophenotype | Acute myeloid leukemia | GENE-MUTATIONS | AML | CYTOPLASMIC NUCLEOPHOSMIN | ACUTE MYELOGENOUS LEUKEMIA | CLASSIFICATION | TANDEM DUPLICATION | NORMAL KARYOTYPE | ONCOLOGY | FAVORABLE PROGNOSIS | NPM1 MUTATION | HEMATOLOGY | EXPRESSION | Antigens, CD - immunology | Prognosis | Humans | Middle Aged | Child, Preschool | Male | Monocytes - immunology | Leukemia, Myeloid, Acute - immunology | Antigens, CD - metabolism | Young Adult | Flow Cytometry | Myeloid Cells - immunology | Monocytes - pathology | Aged, 80 and over | Adult | Female | Retrospective Studies | Nuclear Proteins - genetics | Child | HLA-DR Antigens - metabolism | Leukemia, Myeloid, Acute - pathology | Immunophenotyping | Mutation - genetics | Adolescent | Chromosome Aberrations | Aged | HLA-DR Antigens - immunology | Myeloid Cells - pathology | Leukemia, Myeloid, Acute - genetics | Fc receptors | Analysis
Journal Article